Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
975.0000 -44.25 (-4.34%)
NSE Sep 26, 2025 15:31 PM
Volume: 2.6M
High volume today

975.00
-4.34%
ICICI Securities Limited
Zydus Lifesciences’ (Zydus) Q4FY23 performance was driven by traction in its existing products and exclusive launches such as gRevlimid and gTrokendi XR. Revenue growth and margins of the base business were also quite healthy in our opinion.
Zydus Lifesciences Ltd.'s price crossed below 30Day SMA today
More from Zydus Lifesciences Ltd.
Recommended